? What Is The Oncomine CML Panel Test?
The Oncomine Chronic Myeloid Leukemia (CML) Panel is a specialized genetic test that utilizes next-generation sequencing (NGS) technology to detect key mutations in genes related to Chronic Myeloid Leukemia. It helps to diagnose, monitor treatment efficacy, and guide personalized therapy by identifying mutations such as the Philadelphia chromosome (BCR-ABL1).

? Why Do People In Dubai Choose This Test?

✔️ Detects the BCR-ABL1 fusion gene, the hallmark of CML
✔️ Identifies resistance mutations to common therapies like Imatinib
✔️ Aids in treatment planning and clinical trial eligibility
✔️ Helps with risk stratification and prognosis
✔️ Preferred by hematologists and oncologists in Dubai’s top medical centers

? Methodology Of The Test

1. Sample Collection:
   A blood sample or bone marrow aspirate is taken from the patient.

2. DNA/RNA Extraction:
   Genetic material is carefully extracted from the collected sample for molecular analysis.

3. NGS Sequencing & Detection:
   The test utilizes next-generation sequencing (NGS) to detect mutations such as BCR-ABL1, T315I, and other resistance mutations.

4. Data Analysis & Reporting:
   The genetic data is interpreted using advanced bioinformatics tools, and a detailed report is provided within 7–14 working days.

? Cost Of Oncomine CML Panel In Dubai

The cost of the Oncomine CML Panel typically ranges from AED 3,000 – AED 6,000, depending on the lab, number of genes tested, and the complexity of the report.

? Where To Get The Test In Dubai

The Oncomine CML Panel is available at leading healthcare facilities in Dubai, including:
• American Hospital Dubai
• Al Zahra Hospital
• Mediclinic City Hospital
• King’s College Hospital Dubai
• NMC Specialty Hospital

?‍♀️ Frequently Asked Questions (FAQ)

Q1: What mutations does the Oncomine CML Panel test for?
It primarily detects the BCR-ABL1 fusion gene, along with other resistance mutations like T315I.

Q2: How is this test different from a regular CML test?
This test offers comprehensive molecular profiling, including mutations that may cause drug resistance and help guide personalized treatment.

Q3: Is the test only for diagnosed CML patients?
While it’s primarily used for diagnosis, it is also helpful for monitoring treatment efficacy and identifying relapse or resistance mutations.

Q4: How long does it take to get the results?
The results are typically available within 7 to 14 working days.

Q5: Is this test required before starting CML treatment?
It’s highly recommended to ensure that treatment decisions are based on the specific genetic profile of the patient.

✅ Conclusion
The Oncomine Chronic Myeloid Leukemia (CML) Panel is a groundbreaking tool in the personalized treatment of CML. By identifying genetic mutations like the BCR-ABL1 fusion gene and resistance mutations, it provides crucial insights into treatment planning, prognosis, and therapy selection. If you’re in Dubai and dealing with CML, this test offers the precise information needed for effective management. Consult your oncologist or hematologist and consider getting tested today to take a step toward tailored, effective care.